Optimization of Preparation Process of Xiaoyao Tablets by Mixture Design Method Based on QbD Concept

LI Hui-ting; WU Zhen-feng; ZHANG Xiao-fei; LI Yuan-hui; LI Yan-nian; LIU En-wei; LI Xiao-feng; YANG Ming

doi:10.13422/j.cnki.syfjx.20181006

您当前的位置：

首页 >

文章列表页 >

Optimization of Preparation Process of Xiaoyao Tablets by Mixture Design Method Based on QbD Concept

更新时间：2024-01-04

- Optimization of Preparation Process of Xiaoyao Tablets by Mixture Design Method Based on QbD Concept
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 15, Pages: 36-42(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20181006
  CLC： TQ461
- Published：2018
- 稿件说明：
移动端阅览
LI Hui-ting, WU Zhen-feng, ZHANG Xiao-fei, et al. Optimization of Preparation Process of Xiaoyao Tablets by Mixture Design Method Based on QbD Concept[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(15): 36-42.
DOI：

LI Hui-ting, WU Zhen-feng, ZHANG Xiao-fei, et al. Optimization of Preparation Process of Xiaoyao Tablets by Mixture Design Method Based on QbD Concept[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(15): 36-42. DOI： 10.13422/j.cnki.syfjx.20181006.

摘要

目的：基于质量源于设计（QbD）理念优化逍遥片的处方配比及制备工艺。方法：采用湿法制粒压片法制备逍遥片。评估可能影响片剂质量的风险因素，采用Plackett-Burman设计筛选对评价指标有显著性影响的处方因素及工艺参数，以颗粒成型率、颗粒休止角、片剂外观及崩解时间为评价指标，通过混料设计法优化逍遥片的处方配比。结果：通过风险评估和Plackett-Burman试验确定了药辅比、填充剂中淀粉与乳糖的比例、崩解剂用量和润滑剂用量4个处方因素为影响实验结果的关键因素，通过混料设计建立的回归模型具有显著性意义，模型具有良好预测性，基于模型在最佳处方区域内选择的优化处方为逍遥片干浸膏粉-淀粉-乳糖-交联羧甲基纤维素钠-硬脂酸镁（73.2∶13.8∶10∶2∶1），按此处方制备逍遥片，颗粒成型率、颗粒休止角、外观评分及崩解时间平均值分别为87.44%，34.97度，5分，32.3 min，平均综合评分为75.63分。结论：基于QbD理念及混料设计法对逍遥片的处方及工艺参数进行优化是可行的，所得的处方合理，工艺条件稳定，可为逍遥片的大生产提供参考。

Abstract

Objective: To optimize the formulation and preparation technology of Xiaoyao tablets based on quality by design (QbD). Method:Xiaoyao tablets were prepared by wet granulation and granule compression.Firstly

the risk factors that may affect the quality of the tablets were evaluated.Plackett-Burman experimental design was used to screen the prescription factors and process parameters that had significant influence on the index.Taking formability of granules

angle of repose and appearance of tablets

disintegration time as evaluation indexes

the formulation of Xiaoyao tablets was optimized by mixture design. Result:By taking risk assessment and Plackett-Burman test

it was confirmed that the ratio of extract powder to excipients

the ratio of starch to lactose

the amount of disintegrant and lubricant were the key factors affecting the experimental results.The regression model established by the mixture design had significant significance and the model had good predictability.Based on the model

the optimal formulation was chosen within the optimal prescription area as dry extract powder-starch-lactose-croscarmellose sodium-magnesium stearate (73.2:13.8:10:2:1).According to this prescription

Xiaoyao tablets was prepared

its average particle forming rate reached 87.44%

the angle of repose was 34.97°

the score of tablets' appearance was 5 points and the disintegration time was 32.3 minutes

the comprehensive score reached 75.63 points. Conclusion:It is feasible to optimize the prescription and process parameters of Xiaoyao tablets based on QbD concept and mixture design method.The prescription optimized by mixture design is reasonable

the process is stable and feasible

which can provide a reference for industrial production of Xiaoyao tablets.

关键词

Keywords

references

Views

329

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Discussion on Development Status of Traditional Chinese Medicine Dispensing Granules and Survival Strategy of Enterprises

Determination and Risk Assessment of Six Hepatotoxic Pyrrolizidine Alkaloids in Verbenae Herba

Application of FMEA and Bayesian Network in Risk Assessment of Fluidized Bed Granulation of Traditional Chinese Medicine

Study on Application of Experiment Design Methods in Optimizing Preparation of Yuanhuzhitong Dispersible Tablet

Related Author

WANG Tao

LIU Shuqi

LI Yaohong

YANG Zhengming

YAN Xinjia

ZHOU Houcheng

LI Wenbing

CHEN Shilin

Related Institution

Key Laboratory of Qinghai-Xizang Plateau Ethnic Medicinal Resources Protection and Utilization of National Ethnic Affairs Commission，Sichuan Engineering Laboratory of Qiang-Yi Medicinal Resources Protection and Utilization Technology，Southwest Minzu University

The Third People's Hospital of Bijie City

Sichuan Neo-green Pharmaceutical Technology Development Co. Ltd.，Pengzhou

Chengdu University of Traditional Chinese Medicine

National Institutes for Food and Drug Control

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰